Prime Therapeutics notes lower hospitalization rate among adherent diabetics
ST. PAUL, Minn. — Diabetes patients who adhere to their medication therapies have a significantly lower risk of hospitalization, according to a new study scheduled for presentation this week at the Academy of Managed Care Pharmacy’s 23rd annual meeting and showcase in Minneapolis.
The study, conducted by pharmacy benefit manager Prime Therapeutics using data from more than 15,000 patients, found that medication adherence among diabetes patients cut the risk of hospitalization by 31%, compared with patients who were not compliant.
“Our research found adherent individuals had $1,010 lower medical costs during the year,” Prime director for clinical outcomes assessment Patrick Gleason said. “Besides the medical cost savings, patients that adhere to their medications are likely to have improved health and increased quality of life. Yet in this study, we found one-quarter of patients do not stick to their diabetes medication, so the medical community must find ways to increase adherence for those most at risk.”